bazedoxifene
Selected indexed studies
- Bazedoxifene for the treatment of osteoporosis. (Expert Opin Pharmacother, 2019) [PMID:31091133]
- Bazedoxifene for HRT? (Drug Ther Bull, 2017) [PMID:28408389]
- Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling. (Curr Oncol, 2024) [PMID:39451730]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Bazedoxifene for the treatment of osteoporosis. (2019) pubmed
- Bazedoxifene for HRT? (2017) pubmed
- Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling. (2024) pubmed
- Conjugated oestrogens/bazedoxifene. (2017) pubmed
- Bazedoxifene. (2026) pubmed
- Bazedoxifene plus conjugated estrogens improve menopausal symptoms in postmenopausal women: a systematic review and meta-analysis. (2022) pubmed
- Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation. (2022) pubmed
- A comprehensive review on anticancer mechanism of bazedoxifene. (2022) pubmed
- Bazedoxifene: a review of its use in the treatment of postmenopausal osteoporosis. (2011) pubmed
- Bazedoxifene (Wyeth). (2004) pubmed